Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening
about
New hepatitis C virus drug discovery strategies and model systemsDevelopment of NS3/4A Protease-Based Reporter Assay Suitable for Efficiently Assessing Hepatitis C Virus InfectionA cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycleHigh-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virusA major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approachHepatitis C virus experimental model systems and antiviral drug research.Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assayDevelopment of a homogeneous high-throughput screening assay for biological inhibitors of human rhinovirus infection.Potential treatment options and future research to increase hepatitis C virus treatment response rateQuantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.Antioxidant and Anti-Hepatitis C Viral Activities of Commercial Milk Thistle Food SupplementsIdentification of 23-(s)-2-amino-3-phenylpropanoyl-silybin as an antiviral agent for influenza A virus infection in vitro and in vivoDetermining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spreadBiology in a gray box: targeting the emergent properties of protein complexes: 2011 Yale Chemical Biology Symposium.Fluorescence resonance energy transfer-based intracellular assay for the conformation of hepatitis C virus drug target NS5A.Screening of hepatitis C virus inhibitors using genotype 1a HCV replicon cell lines.Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening.Hepatitis C virus infection in living color.
P2860
Q26851159-63B1F0D9-5C30-42C9-9061-B2C98FDC8F99Q27490296-544F6E24-ED13-4BF3-930D-02C8980B5FF4Q27491288-261B5C55-3800-49DB-94E9-31CEDDE19CABQ28482091-F6EFA8B0-3DCA-41B0-9F4A-DDBE5DE344C9Q33707739-1C66CEFB-4E11-42EB-9753-E558856D1157Q34235286-94FA5186-9D2A-4556-89E9-1B5B2A3699F7Q34251341-C354A83F-F23E-4890-93CE-5BF8C48B951DQ34403294-10F305E7-EE1D-4D02-8D55-38BCB431F0DFQ34498975-816427D7-48AE-4C0A-B688-6E93FACAA7C4Q34576190-4F0E8B2C-89AE-4D9E-B94C-8D3E51F442E2Q35745457-507338D5-ACA9-41ED-BFA2-BE7874CF98D7Q36334863-E3EB0ACE-1AA0-4A37-A255-D8E0EDEF6D18Q37124162-3A9F3BFF-E10F-486F-8818-0799FE938B89Q37713961-FEDAA19A-CAB5-44DC-A7E8-CED26C6B7B0BQ37969747-C8F318E8-CA04-4175-9F14-3F372FAFE6A6Q39343070-80BF260C-BECD-4126-929D-E3377577FCB1Q39497196-2683C0C7-3583-43E5-986F-DCCA74695827Q39628176-E23D8D1C-26BD-48B9-B886-E5626AB58BDFQ39660432-66EDAC43-B048-471E-9FC3-C23FCA486463Q43417751-6184189E-DDCD-483F-B522-8C11A16AADEF
P2860
Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Development of a Cell-Based He ...... t Antiviral Compound Screening
@ast
Development of a Cell-Based He ...... t Antiviral Compound Screening
@en
Development of a Cell-Based He ...... t Antiviral Compound Screening
@nl
type
label
Development of a Cell-Based He ...... t Antiviral Compound Screening
@ast
Development of a Cell-Based He ...... t Antiviral Compound Screening
@en
Development of a Cell-Based He ...... t Antiviral Compound Screening
@nl
prefLabel
Development of a Cell-Based He ...... t Antiviral Compound Screening
@ast
Development of a Cell-Based He ...... t Antiviral Compound Screening
@en
Development of a Cell-Based He ...... t Antiviral Compound Screening
@nl
P2093
P2860
P356
P1476
Development of a Cell-Based He ...... t Antiviral Compound Screening
@en
P2093
Bruno Sainz
Susan L Uprichard
P2860
P304
P356
10.1128/AAC.00495-09
P407
P577
2009-10-01T00:00:00Z